Zobrazeno 1 - 10
of 243
pro vyhledávání: '"Abdulgabar, Salama"'
Publikováno v:
Cellular Physiology and Biochemistry, Vol 53, Iss 3, Pp 453-464 (2019)
Externí odkaz:
https://doaj.org/article/d84473b34a764e33ae200d90b4588ece
Autor:
Frauke Ringel, Holger Kiesewetter, Beate Mayer, Thilo Bartolmäs, Jalid Sehouli, Abdulgabar Salama
Publikováno v:
Transfusion. 62:2648-2652
Hemolysis after Oral Artemisinin Combination Therapy for Uncomplicated Plasmodium falciparum Malaria
Autor:
Florian Kurth, Tilman Lingscheid, Florian Steiner, Miriam S. Stegemann, Sabine Bélard, Nikolai Menner, Peter Pongratz, Johanna Kim, Horst von Bernuth, Beate Mayer, Georg Damm, Daniel Seehofer, Abdulgabar Salama, Norbert Suttorp, Thomas Zoller
Publikováno v:
Emerging Infectious Diseases, Vol 22, Iss 8, Pp 1381-1386 (2016)
Episodes of delayed hemolysis 2–6 weeks after treatment of severe malaria with intravenous artesunate have been described. We performed a prospective observational study of patients with uncomplicated malaria to investigate whether posttreatment he
Externí odkaz:
https://doaj.org/article/5f183e4c685341d297060a380448f793
Publikováno v:
PLoS ONE, Vol 13, Iss 6, p e0198184 (2018)
BACKGROUND:Many patients with immune thrombocytopenia (ITP) may require special attention and long-term treatment. Little is known on the efficacy and tolerability of the drugs used in practice. MATERIAL AND METHODS:We retrospectively reviewed the re
Externí odkaz:
https://doaj.org/article/704042a0c73e4ff3b9df9a23fcd2505d
Autor:
Frauke Ringel, Falk Lewandofski, Holger Kiesewetter, Jalid Sehouli, Berthold Hoppe, Alina Kiesewetter, Reinhard Hannen, Christian Friedrich Stoll, Sylvia Maas, Gülden Halis, Abdulgabar Salama
Objective: Coating of autologous red blood cells (RBCs) with polyclonal antibodies to Rh(D) antigen may result in an immunomodulation and improved outcome in Rh(D) positive women with recurrent pregnancy loss (RPL). Design: Retrospective data analysi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::82197368667b75ce3adfbdb5dfca7b0f
https://doi.org/10.22541/au.166971068.86827188/v1
https://doi.org/10.22541/au.166971068.86827188/v1
Publikováno v:
Transfusion Medicine. 29:48-54
Objectives To assess the efficacy and safety of intravenous immunoglobulin (IVIG) 10% (Panzyga® ), a novel human normal IVIG 10%, in patients with chronic immune thrombocytopenia (ITP). Background First-line treatment options in ITP include IVIGs. M
Autor:
Gürkan Bal, Julian Kamhieh-Milz, Viktor Sterzer, Muhammad Al-Samman, Janusz Debski, Oliver Klein, Sundrela Kamhieh-Milz, Sucharit Bhakdi, Abdulgabar Salama
Publikováno v:
Cell Transplantation, Vol 22 (2013)
Human umbilical cord vein endothelial cells (HUVECs) secrete a number of factors that greatly impact the proliferation and differentiation of hematopoietic stem and progenitor cells (HSPCs). These factors remain largely unknown. Here, we report on th
Externí odkaz:
https://doaj.org/article/e9930499899b453498f345f7cb127484
Autor:
Frauke Ringel, Helge Schoenfeld, Said El Bali, Jalid Sehouli, Claudia Spies, Abdulgabar Salama
Publikováno v:
Transfusion medicine and hemotherapy : offizielles Organ der Deutschen Gesellschaft fur Transfusionsmedizin und Immunhamatologie. 49(4)
Introduction: Uncrossmatched ABO-compatible red blood cells (RBCs) are generally recommended in patients with life-threatening massive bleeding. There is little data regarding RBC transfusion when patients are transfused against clinically significan
Autor:
Gürkan Bal, Julian Kamhieh-Milz, Matthias Futschik, Thomas Häupl, Abdulgabar Salama, Anja Moldenhauer
Publikováno v:
Cell Transplantation, Vol 21 (2012)
Endothelial cells can be successfully used to maintain or increase the number of hematopoietic stem cells in vitro. Previously we identified hematopoietic progenitor cell (HPC) expansion or survival benefit induced by IL-1β-, IL-3-, and IL-6-stimula
Externí odkaz:
https://doaj.org/article/79cd7e9ca5514510864bce7c1640fe59
Autor:
Maria Socorro O Portella, Jasmina I. Ivanova, Mei Sheng Duh, Abderrahim Khelif, Abdulgabar Salama, Mansoor N. Saleh, Kelly M. Grotzinger, Anuja Roy, James B. Bussel
Publikováno v:
American Journal of Hematology
Patients with persistent/chronic immune thrombocytopenia (cITP) have low platelet counts, increased risk of bleeding and bruising, and often suffer from reduced health‐related quality of life (HRQoL). cITP treatments may either improve HRQoL by inc